{"id":12381,"date":"2024-01-04T11:20:00","date_gmt":"2024-01-04T10:20:00","guid":{"rendered":"https:\/\/mrl-munich.com\/dr-franz-koehler-chemie-establishment-of-its-own-subsidiary-in-china-with-an-innovative-shareholder-model\/"},"modified":"2025-07-14T10:49:09","modified_gmt":"2025-07-14T08:49:09","slug":"dr-franz-koehler-chemie-establishment-of-its-own-subsidiary-in-china-with-an-innovative-shareholder-model","status":"publish","type":"post","link":"https:\/\/mrl-munich.com\/en\/dr-franz-koehler-chemie-establishment-of-its-own-subsidiary-in-china-with-an-innovative-shareholder-model\/","title":{"rendered":"Dr. Franz K\u00f6hler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model"},"content":{"rendered":"\n

By Frank-Christian Raffel<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>
\n

Dr. Franz K\u00f6hler Chemie (DFKC)<\/a> is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL\u00a9, which is distributed worldwide by DFKC. <\/p>\n<\/div><\/div>\n\n\n\n

Starting Point<\/mark><\/strong><\/p>\n\n\n\n

\n
\n

China is one of the most important markets in the world for DFKC. Due to the excellent health effects of CUSTODIOL\u00a9, DFKC entered the market very early on in cooperation with Chinese distributors.<\/p>\n<\/div>\n\n\n\n

\n
\n

MRL Advisors carried out a market and competition analysis for DFKC in China, which confirmed the potential that was assumed to still exist.<\/em><\/p>\n<\/blockquote>\n<\/div>\n<\/div>\n\n\n\n

Objectives DFKC<\/mark><\/strong><\/p>\n\n\n\n

The management of DFKC had decided to establish a separate corporate presence in order to better exploit the market potential, improve the strategic management of activities and implement the brand strategy in China. The two Chinese distributors were invited by DFKC to participate in a joint venture.<\/p>\n\n\n\n

Tasks of MRL Advisors<\/strong><\/mark><\/p>\n\n\n\n

MRL has been commissioned by DFKC to structure and negotiate a joint venture with the two Chinese distributors and DFKC. <\/p>\n\n\n\n

\"\"<\/figure>
\n

MRL has implemented a structure that gives DFKC ultimate control over its business activities in China (Note: Frank-Christian Raffel has already conducted a study on success factors of China engagement together with the AHK in Hong Kong and Shanghai among more than 400 German companies with a presence in China in 1997, from which key findings have been incorporated into the consulting practice of MRL Advisors; see below).<\/p>\n\n\n\n

Image: DFKC, Custodiol<\/em><\/p>\n<\/div><\/div>\n\n\n\n

Result: target-oriented joint venture model<\/mark><\/strong><\/p>\n\n\n\n

The model developed and negotiated by MRL Advisors, Frank-Christian Raffel in the lead for DFKC in China has the following key points:<\/p>\n\n\n\n